Opinion
Video
The Role for Systematic Biopsy Plus MRI-Targeted Procedures
Author(s):
Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
Video Player is loading.
Video content above is prompted by the following questions:
- What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
- How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Investigators assess ctDNA’s role in NMIBC
Laura Davis, MD, on persistent poverty and early onset prostate cancer
Alicia Morgans, MD, highlights the phase 3 ARASTEP trial
Ruben Olivares, MD, discusses HIFU and remote prostate cancer care
Mitchell Huang, MD, on the cost-effectiveness of transperineal vs transrectal prostate biopsy
Alicia Morgans, MD, on QOL outcomes with darolutamide plus ADT in mHSPC
Post-RP incontinence: Low procedure rates examined
Data link incontinence severity to post-radical prostatectomy care
Jim Hu, MD, on upgrading of GG1 prostate cancer at radical prostatectomy
Expert discusses differentiating prostate cancer from age-related issues
Related Content
